首页> 外文期刊>Anesthesiology >Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents.
【24h】

Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents.

机译:利多卡因和带永久电荷的钠通道阻滞剂QX-314的共同使用可在啮齿动物中产生持久的伤害感受性阻滞作用。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Nociceptive-selective local anesthesia is produced by entry of the permanently charged lidocaine-derivative QX-314 into nociceptors when coadministered with capsaicin, a transient receptor potential vanilloid 1 (TRPV1) channel agonist. However, the pain evoked by capsaicin before establishment of the QX-314-mediated block would limit clinical utility. Because TRPV1 channels are also activated by lidocaine, the authors tested whether lidocaine can substitute for capsaicin to introduce QX-314 into nociceptors through TRPV1 channels and produce selective analgesia. METHODS: Lidocaine (0.5% [17.5 mM], 1% [35 mM], and 2% [70 mM]) alone, QX-314 (0.2% [5.8 mM]) alone, and a combination of the two were injected subcutaneously and adjacent to the sciatic nerve in rats and mice. Mechanical and thermal responsiveness were measured, as was motor block. RESULTS: Coapplication of 0.2% QX-314 with lidocaine prolonged the nociceptive block relative to lidocaine alone, an effect attenuated in TRPV1 knockout mice. The 0.2% QX-314 alone had no effect when injected intraplantary or perineurally, and it produced only weak short-lasting inhibition of the cutaneous trunci muscle reflex. Perisciatic nerve injection of lidocaine with QX-314 produced a differential nociceptive block much longer than the transient motor block, lasting 2 h (for 1% lidocaine) to 9 h (2% lidocaine). Triple application of lidocaine, QX-314, and capsaicin further increased the duration of the differential block. CONCLUSIONS: Coapplication of lidocaine and its quaternary derivative QX-314 produces a long-lasting, predominantly nociceptor-selective block, likely by facilitating QX-314 entry through TRPV1 channels. Delivery of QX-314 into nociceptors by using lidocaine instead of capsaicin produces sustained regional analgesia without nocifensive behavior.
机译:背景:与永久性受体电位类香草素1(TRPV1)通道激动剂辣椒素共同使用时,永久充电的利多卡因衍生物QX-314进入伤害感受器后,才产生伤害选择性的局部麻醉。但是,在建立QX-314介导的阻滞剂之前,辣椒素引起的疼痛会限制临床效用。由于利多卡因还可以激活TRPV1通道,因此作者测试了利多卡因是否可以替代辣椒素以通过TRPV1通道将QX-314引入伤害感受器并产生选择性镇痛作用。方法:单独使用利多卡因(0.5%[17.5 mM],1%[35 mM]和2%[70 mM]),单独QX-314(0.2%[5.8 mM]),以及两者的组合皮下注射在大鼠和小鼠中与坐骨神经相邻。测量了机械响应和热响应,以及电机阻滞。结果:相对于单独使用利多卡因,与利多卡因共同应用0.2%QX-314可延长伤害性阻滞,这种作用在TRPV1基因敲除小鼠中减弱。单独的0.2%QX-314在种植体内或会阴周围注射时没有作用,并且仅产生对皮肤截短肌反射的弱短期抑制作用。使用QX-314的经皮神经神经注射利多卡因产生的差异性伤害性阻滞比短暂的运动阻滞长得多,持续2小时(对于1%利多卡因)至9小时(2%利多卡因)。利多卡因,QX-314和辣椒素的三次应用进一步增加了差异阻滞剂的持续时间。结论:利多卡因及其四级衍生物QX-314的共同应用可产生持久的,主要是伤害感受器选择性的阻滞剂,可能是通过促进QX-314通过TRPV1通道进入而产生的。通过使用利多卡因而不是辣椒素将QX-314传递至伤害感受器可产生持续的区域镇痛作用,而没有伤害行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号